It mediates important physiological effects of the endogenous peptide, GLP-1, in regulating insulin secretion, carbohydrate metabolism and appetite, and thus is well established as a long term clinical target for treating type II diabetes and obesity (Graaf et al
GHK-Cu is compatible with other active ingredients including hyaluronic acid, niacinamide, and peptide serums
Medications are just one piece of the puzzle, though
If you're experiencing any disruptive side effects, or you have questions about Trulicity dosing, always reach out to your health provider.
It is important to remember, however, that this trial was an open-label study that is to say, the participants knew that they were receiving the exenatide treatment so there is the possibility of a placebo effect explaining the improvements